Cell cycle-dependent cytotoxic and cytostatic effects of bortezomib on colon carcinoma cells.
A
A
Coquelle
S
S
Mouhamad
M O
MO
Pequignot
T
T
Braun
G
G
Carvalho
S
S
Vivet
D
D
Métivier
M
M
Castedo
G
G
Kroemer
D000970:Antineoplastic Agents / Q000494:pharmacology*; D001897:Boronic Acids / Q000494:pharmacology*; D000069286:Bortezomib; D002277:Carcinoma / Q000188:drug therapy*; D002453:Cell Cycle / Q000187:drug effects*; D003110:Colonic Neoplasms / Q000188:drug therapy*; D019926:Cyclin B / Q000378:metabolism; D006801:Humans; D011719:Pyrazines / Q000494:pharmacology*; D051996:Transcription Factor RelA / Q000378:metabolism
D000970:Antineoplastic Agents; D001897:Boronic Acids; D019926:Cyclin B; D011719:Pyrazines; D051996:Transcription Factor RelA; D000069286:Bortezomib